Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  734 results for ""Cystinosis""

Your Filters

Subject : cysteamine
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Intermediate cystinosis: a case report of 10-year treatment with cysteamine.

  • Authors : Kawamura M; Department of Nephrology, Center Hospital of the National Center for Global Health and Medicine (NCGM), 1-21-1 Toyama Shinjuku-Ku, Tokyo, 162-8655, Japan.; Katagiri D

Subjects: Cysteamine*/Cysteamine*/Cysteamine*/therapeutic use ; Cystinosis*/Cystinosis*/Cystinosis*/drug therapy ; Cystinosis*/Cystinosis*/Cystinosis*/complications

  • Source: BMC nephrology [BMC Nephrol] 2024 Aug 27; Vol. 25 (1), pp. 275. Date of Electronic Publication: 2024 Aug 27.Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369

Record details

Read More Add to Saved list
×
Academic Journal

Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients.

  • Authors : Kishk OA; Division of Pharmacovigilance, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD, 20993, USA. .; Kim I

Subjects: Cysteamine*/Cysteamine*/Cysteamine*/adverse effects ; Cysteamine*/Cysteamine*/Cysteamine*/administration & dosage ; Cystinosis*/Cystinosis*/Cystinosis*/complications

  • Source: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2024 Aug; Vol. 39 (8), pp. 2429-2433. Date of Electronic Publication: 2024 Mar 11.Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Cysteamine toxicity presenting with acute encephalopathy and spastic tetraparesis.

  • Authors : Allen C; Wessex Neurological Centre, Southampton General Hospital, Tremona Road, University Hospital Southampton NHS Foundation Trust, Southampton, UK .; Armstrong K

Subjects: Cysteamine*/Cysteamine*/Cysteamine*/adverse effects ; Quadriplegia*/Quadriplegia*/Quadriplegia*/chemically induced ; Quadriplegia*/Quadriplegia*/Quadriplegia*/etiology

  • Source: Practical neurology [Pract Neurol] 2024 Nov 17; Vol. 24 (6), pp. 515-518. Date of Electronic Publication: 2024 Nov 17.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101130961 Publication Model: Electronic Cited Medium: Internet ISSN: 1474-7766

Record details

Read More Add to Saved list
×
Academic Journal

Plasma chitotriosidase enzyme activity as a novel therapeutic monitor for cysteamine treatment in nephropathic cystinosis: A retrospective validation study.

  • Authors : Veys K; Department of Pediatrics, University Hospitals Leuven, campus Gasthuisberg, Leuven, Belgium; Department of Development & Regeneration, Laboratory of Pediatric Nephrology, KU Leuven, campus Gasthuisberg, Leuven, Belgium.

Subjects: Cysteamine*/Cysteamine*/Cysteamine*/therapeutic use ; Cystinosis*/Cystinosis*/Cystinosis*/drug therapy ; Cystinosis*/Cystinosis*/Cystinosis*/blood

  • Source: Molecular genetics and metabolism [Mol Genet Metab] 2024 May; Vol. 142 (1), pp. 108454. Date of Electronic Publication: 2024 Mar 21.Publisher: Academic Press Country of Publication: United States NLM ID: 9805456 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

ZenoSWATH DIA proteomics and clustering analysis of the effect of cysteamine at the cellular level in cystinotic fibroblasts.

  • Authors : Ortea I; Proteomics Unit, Centro de Investigación en Nanomateriales y Nanotecnología (CINN-CSIC), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo 33011, Spain.; Rodríguez-Martínez L

Subjects: Cysteamine*/Cysteamine*/Cysteamine*/pharmacology ; Cystinosis*/Cystinosis*/Cystinosis*/drug therapy ; Cystinosis*/Cystinosis*/Cystinosis*/metabolism

  • Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Dec; Vol. 181, pp. 117650. Date of Electronic Publication: 2024 Nov 06.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Human and animal fertility studies in cystinosis reveal signs of obstructive azoospermia, an altered blood-testis barrier and a subtherapeutic effect of cysteamine in testis.

  • Authors : Reda A; Laboratory of Pediatric Nephrology, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.; Biology of the Testis (BITE) Laboratory, Department of Reproduction, Genetics and Regenerative Medicine, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Subjects: Azoospermia/Azoospermia/Azoospermia/*pathology ; Blood-Testis Barrier/Blood-Testis Barrier/Blood-Testis Barrier/*metabolism ; Cysteamine/Cysteamine/Cysteamine/*therapeutic use Cystinosis, Infantile Nephropathic

  • Source: Journal of inherited metabolic disease [J Inherit Metab Dis] 2021 Nov; Vol. 44 (6), pp. 1393-1408. Date of Electronic Publication: 2021 Sep 24.Publisher: Wiley Country of Publication: United States NLM ID: 7910918 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2665

Record details

Read More Add to Saved list
×
Academic Journal

Response to Cysteamine in Osteoclasts Obtained from Patients with Nephropathic Cystinosis: A Genotype/Phenotype Correlation.

  • Authors : Quinaux T; Centre de Référence des Maladies Rénales Rares, Centre de Référence des Maladies Rares du Calcium et du Phosphore, Filières de Santé Maladies Rares OSCAR, ORKID et ERK-Net, Hôpital Femme Mère Enfant, 69500 Bron, France.; INSERM 1033 Research Unit, 69008 Lyon, France.

Subjects: Cysteamine/Cysteamine/Cysteamine/*pharmacology ; Cystinosis/Cystinosis/Cystinosis/*genetics ; Osteoclasts/Osteoclasts/Osteoclasts/*metabolism

  • Source: Cells [Cells] 2021 Sep 21; Vol. 10 (9). Date of Electronic Publication: 2021 Sep 21.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details

Read More Add to Saved list
×
Academic Journal

The TGM2 inhibitor cysteamine hydrochloride does not impact corneal epithelial and stromal wound healing in vitro and in vivo.

  • Authors : Minella AL; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, CA, USA.; Casanova MI

Subjects: Corneal Injuries*/Corneal Injuries*/Corneal Injuries*/drug therapy ; Corneal Injuries*/Corneal Injuries*/Corneal Injuries*/metabolism ; Cysteamine*/Cysteamine*/Cysteamine*/pharmacology

  • Source: Experimental eye research [Exp Eye Res] 2023 Jan; Vol. 226, pp. 109338. Date of Electronic Publication: 2022 Dec 05.Publisher: Academic Press Country of Publication: England NLM ID: 0370707 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride.

  • Authors : Liang H; Sorbonne Universités, INSERM, CNRS, Institut de la Vision, Paris, France .; Labbé A

Subjects: Visual Acuity*; Cornea/Cornea/Cornea/*metabolism ; Cysteamine/Cysteamine/Cysteamine/*administration & dosage

  • Source: The British journal of ophthalmology [Br J Ophthalmol] 2021 May; Vol. 105 (5), pp. 608-613. Date of Electronic Publication: 2020 Jun 27.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0421041 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Bone Disease in Nephropathic Cystinosis: Beyond Renal Osteodystrophy.

  • Authors : Machuca-Gayet I; Pathophysiology, diagnosis and treatment of bone diseases, INSERM UMR 1033, 69008 Lyon, France.; Quinaux T

Subjects: Bone Diseases/Bone Diseases/Bone Diseases/*etiology ; Cysteamine/Cysteamine/Cysteamine/*therapeutic use ; Cystinosis/Cystinosis/Cystinosis/*drug therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2020 Apr 28; Vol. 21 (9). Date of Electronic Publication: 2020 Apr 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read More Add to Saved list
×
  • 1-10 of  734 results for ""Cystinosis""